Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07844603
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Registry
-
NCT07844603
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07844603. Randomized; no masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME)
- Acronym
- CoPRIME
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Aspirin + Clopidogrel
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Aspirin + Ticagrelor
- Lead sponsor
- University of Alberta
- Collaborator
- University of Calgary
Record details
- Record id
cardio:ct-nct07844603- Content hash
a8740235fefead5522fec6896006e533055b8608207560ba0b89f29d5bc6f489